Cvkd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cvkd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cvkd Today - Breaking & Trending Today
Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) is one of 988 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare Cadrenal Therapeutics to related businesses based on the strength of its earnings, dividends, risk, analyst recommendations, institutional ownership, profitability and valuation. Analyst Ratings This is a […] ....
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 21,900 shares, an increase of 204.2% from the February 29th total of 7,200 shares. Based on an average daily trading volume, of 340,600 shares, the short-interest […] ....
Noble Financial assumed coverage on shares of Cadrenal Therapeutics (NASDAQ:CVKD – Free Report) in a research note released on Monday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $4.00 price target on the stock. Separately, HC Wainwright reissued a buy rating and set a $3.00 price target on shares of Cadrenal Therapeutics […] ....
HC Wainwright reissued their buy rating on shares of Cadrenal Therapeutics (NASDAQ:CVKD – Free Report) in a research note issued to investors on Monday morning, MarketBeat reports. HC Wainwright currently has a $3.00 target price on the stock. HC Wainwright also issued estimates for Cadrenal Therapeutics’ Q4 2023 earnings at ($0.09) EPS, FY2023 earnings at […] ....
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 14,400 shares, an increase of 65.5% from the August 31st total of 8,700 shares. Currently, 0.3% of the company’s shares are sold short. […] ....